Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Lymphoid 2Head & Neck 2Gynecologic 2Thoracic 1Sarcoma 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Cervical Intraepithelial Neoplasia Grade 2/3 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cytological Techniques × Gynecologic × Clear all
NCT02067468 2019-09-19

ASCUS-COL

Universidad de Antioquia

Phase NA Completed
2,661 enrolled 18 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03366493 2017-12-08

The Study of Folate Receptor-Mediated Staining Solution (FRDâ„¢) In Cervical Lesion Detection

GY Highland Biotech LLC

Phase 3 Unknown
200 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

Data powered by HemOnc (CC BY 4.0) Colophon âš¡